Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 16

Results For "affordable"

712 News Found

Odisha to implement AB PM-JAY scheme
News | January 14, 2025

Odisha to implement AB PM-JAY scheme

The scheme is fully digitized and covers approximately 45% of India's population


PM Modi lays foundation stone of Kris City and bulk Drug Park at Nakkapalli
News | January 09, 2025

PM Modi lays foundation stone of Kris City and bulk Drug Park at Nakkapalli

The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs


Biocon Biologics embarks on a three-stage strategic journey
News | January 08, 2025

Biocon Biologics embarks on a three-stage strategic journey

Successfully transformed the organization from a two-country operation focused on development and manufacturing to a fully integrated company with a strong commercial engine bringing us closer to patients in over 120 countries


Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol
News | January 06, 2025

Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol

40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs


Innovent inks agreement with Roche for Novel DLL3 ADC
News | January 02, 2025

Innovent inks agreement with Roche for Novel DLL3 ADC

Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009


Venus Remedies secures GMP certification for antibiotic carbapenem facility in Moldova
Drug Approval | January 01, 2025

Venus Remedies secures GMP certification for antibiotic carbapenem facility in Moldova

Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026


Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio
News | December 31, 2024

Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio

The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre


Mankind Pharma and Innovent Biologics join forces for cancer care with Sintilimab
News | December 27, 2024

Mankind Pharma and Innovent Biologics join forces for cancer care with Sintilimab

Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India


Thyrocare secures NABL accreditation for its Labs
News | December 27, 2024

Thyrocare secures NABL accreditation for its Labs

Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation


India is the fourth largest medical devices market in Asia: Anupriya Patel
Policy | December 20, 2024

India is the fourth largest medical devices market in Asia: Anupriya Patel

The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities